127 related articles for article (PubMed ID: 21257209)
1. IRF-1 signaling in central nervous system glial cells regulates inflammatory demyelination.
Ren Z; Wang Y; Liebenson D; Liggett T; Goswami R; Stefoski D; Balabanov R
J Neuroimmunol; 2011 Apr; 233(1-2):147-59. PubMed ID: 21257209
[TBL] [Abstract][Full Text] [Related]
2. Role of glial cells in innate immunity and their role in CNS demyelination.
Sriram S
J Neuroimmunol; 2011 Oct; 239(1-2):13-20. PubMed ID: 21907419
[TBL] [Abstract][Full Text] [Related]
3. Estrogen treatment induces a novel population of regulatory cells, which suppresses experimental autoimmune encephalomyelitis.
Matejuk A; Bakke AC; Hopke C; Dwyer J; Vandenbark AA; Offner H
J Neurosci Res; 2004 Jul; 77(1):119-26. PubMed ID: 15197745
[TBL] [Abstract][Full Text] [Related]
4. The innate immune adaptor MyD88 is dispensable for spontaneous autoimmune demyelination in a mouse model of multiple sclerosis.
Wexler AG; Frielle C; Berry G; Budgeon LR; Baccon J; Christensen ND; Waldner H
J Neuroimmunol; 2013 Feb; 255(1-2):60-9. PubMed ID: 23269203
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis.
Ren Z; Wang Y; Tao D; Liebenson D; Liggett T; Goswami R; Stefoski D; Balabanov R
J Neuroimmune Pharmacol; 2010 Jun; 5(2):260-5. PubMed ID: 20177805
[TBL] [Abstract][Full Text] [Related]
6. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F; Tsutsui S; Vergnolle N; Boven LA; Shariat N; Vodjgani M; Warren KG; Andrade-Gordon P; Hollenberg MD; Power C
J Exp Med; 2006 Feb; 203(2):425-35. PubMed ID: 16476770
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Loda E; Balabanov R
Rev Neurosci; 2012 Jan; 23(2):145-52. PubMed ID: 22499673
[TBL] [Abstract][Full Text] [Related]
8. Effects of Porphyromonas gingivalis on the central nervous system: activation of glial cells and exacerbation of experimental autoimmune encephalomyelitis.
Shapira L; Ayalon S; Brenner T
J Periodontol; 2002 May; 73(5):511-6. PubMed ID: 12027253
[TBL] [Abstract][Full Text] [Related]
9. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
De Santi L; Annunziata P; Sessa E; Bramanti P
J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
[TBL] [Abstract][Full Text] [Related]
10. Induction of inhibitory central nervous system-derived and stimulatory blood-derived dendritic cells suggests a dual role for granulocyte-macrophage colony-stimulating factor in central nervous system inflammation.
Hesske L; Vincenzetti C; Heikenwalder M; Prinz M; Reith W; Fontana A; Suter T
Brain; 2010 Jun; 133(Pt 6):1637-54. PubMed ID: 20424288
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma regulates murine interferon-inducible T cell alpha chemokine (I-TAC) expression in dendritic cell lines and during experimental autoimmune encephalomyelitis (EAE).
Hamilton NH; Banyer JL; Hapel AJ; Mahalingam S; Ramsay AJ; Ramshaw IA; Thomson SA
Scand J Immunol; 2002 Feb; 55(2):171-7. PubMed ID: 11896933
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.
Constantin G; Marconi S; Rossi B; Angiari S; Calderan L; Anghileri E; Gini B; Bach SD; Martinello M; Bifari F; Galiè M; Turano E; Budui S; Sbarbati A; Krampera M; Bonetti B
Stem Cells; 2009 Oct; 27(10):2624-35. PubMed ID: 19676124
[TBL] [Abstract][Full Text] [Related]
13. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
[TBL] [Abstract][Full Text] [Related]
14. Endogenous leukemia inhibitory factor production limits autoimmune demyelination and oligodendrocyte loss.
Butzkueven H; Emery B; Cipriani T; Marriott MP; Kilpatrick TJ
Glia; 2006 May; 53(7):696-703. PubMed ID: 16498619
[TBL] [Abstract][Full Text] [Related]
15. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease.
Schluesener HJ; Sobel RA; Linington C; Weiner HL
J Immunol; 1987 Dec; 139(12):4016-21. PubMed ID: 3500978
[TBL] [Abstract][Full Text] [Related]
17. Histamine and histamine receptors in pathogenesis and treatment of multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Neuropharmacology; 2010 Sep; 59(3):180-9. PubMed ID: 20493888
[TBL] [Abstract][Full Text] [Related]
18. Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis.
Murphy AC; Lalor SJ; Lynch MA; Mills KH
Brain Behav Immun; 2010 May; 24(4):641-51. PubMed ID: 20138983
[TBL] [Abstract][Full Text] [Related]
19. New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
El Behi M; Dubucquoi S; Lefranc D; Zéphir H; De Seze J; Vermersch P; Prin L
Immunol Lett; 2005 Jan; 96(1):11-26. PubMed ID: 15585303
[TBL] [Abstract][Full Text] [Related]
20. Neurodegeneration in autoimmune CNS inflammation.
Herz J; Zipp F; Siffrin V
Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]